Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/10495/36864
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.contributor.authorCardona Sánchez, Diana Patricia-
dc.contributor.authorBurbano Levy, Ximena-
dc.contributor.authorPalacios, Elsa-
dc.contributor.authorRico Alba, Israel-
dc.contributor.authorZapata, León-
dc.date.accessioned2023-10-10T18:22:32Z-
dc.date.available2023-10-10T18:22:32Z-
dc.date.issued2014-
dc.identifier.citationBurbano-Levy, X., Qf, D. C., Act, E. P., Alba, I. R., & Qf, L. Z. (2014). Costo Utilidad de Colágena Polivinil-Pirrolidona en el Tratamiento de Osteartrosis de Rodilla en México. Value in health regional issues, 5, 40–47. https://doi.org/10.1016/j.vhri.2014.06.006spa
dc.identifier.issn2212-1099-
dc.identifier.urihttps://hdl.handle.net/10495/36864-
dc.description.abstractABSTRACT: To assess the cost-utility of collagen-polyvinyl pyrrolidone (collagen-PVP), a new drug developed and manufactured in Mexico, compared to non-steroidal anti-inflammatory drugs in the treatment of patients with knee osteoarthritis (OA) in Mexico. Methods: A probabilistic Markov model with a lifetime horizon was designed to evaluate the costs and outcomes (QALYs) of collagen-PVP compared to NSAIDs in patients with OA. Data from randomized clinical trials conducted in México were obtained as input for probabilities. Utility values were elicited from international publications and costs information and service utilization was obtained from official publications of the Instituto Mexicano de Seguro Social - IMSS. Cost per quality adjusted life-years was calculated by using the Mexican Healthcare payer perspective. A discount rate of 5% for both cost and outcomes was used. Sensitivity analyzes were performed with variations in the parameters of gender, age, and price of collagen-PVP. Results: Patients treated with collagen-PVP showed a gain of 6.62 QALYs compared with 5.36 in patients with NSAIDs. The cost-utility ratio was higher in the NSAID group (MEX$ 170,010.76/QALY) compared to collagen-PVP (MEX $ 130,953.63/QALY). The incremental cost-utility ratio was MEX $ 35,194.16. Conclusions: This is the first economic evaluation of a new medication developed in Mexico and conducted partially with local data. The results of this study allow concluding that collagen-PVP is deemed as the dominant alternative compared with NSAIDs in the treatment of knee osteoarthritis.spa
dc.format.extent8spa
dc.format.mimetypeapplication/pdfspa
dc.language.isospaspa
dc.publisherElsevierspa
dc.type.hasversioninfo:eu-repo/semantics/publishedVersionspa
dc.rightsinfo:eu-repo/semantics/openAccessspa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/co/*
dc.titleCosto Utilidad de Colágena Polivinil-Pirrolidona en el Tratamiento de Osteartrosis de Rodilla en Méxicospa
dc.typeinfo:eu-repo/semantics/articlespa
dc.publisher.groupPromoción y Prevención Farmacéuticaspa
dc.identifier.doi10.1016/j.vhri.2014.06.006-
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.rights.accessrightshttp://purl.org/coar/access_right/c_abf2spa
dc.identifier.eissn2212-1102-
oaire.citationtitleValue in Health Regional Issuesspa
oaire.citationstartpage40spa
oaire.citationendpage47spa
oaire.citationvolume5spa
dc.rights.creativecommonshttps://creativecommons.org/licenses/by-nc-nd/4.0/spa
dc.publisher.placeNueva York, Estados Unidosspa
dc.type.coarhttp://purl.org/coar/resource_type/c_2df8fbb1spa
dc.type.redcolhttps://purl.org/redcol/resource_type/ARTspa
dc.type.localArtículo de investigaciónspa
dc.subject.decscost-effectiveness-
dc.subject.decsCost-Effectiveness Analysis-
dc.subject.decsAnálisis Costo-Beneficio-
dc.subject.decsCost-Benefit Analysis-
dc.subject.decsOsteoartritis de la Rodilla-
dc.subject.decsOsteoarthritis, Knee-
dc.subject.decsEnfermedades Reumáticas-
dc.subject.decsRheumatic Diseases-
dc.subject.decsColágeno-
dc.subject.decsCollagen-
dc.subject.decsMéxico-
dc.description.researchgroupidCOL0074661spa
dc.relation.ispartofjournalabbrevValue Health Reg. Issues.spa
Aparece en las colecciones: Artículos de Revista en Farmacéutica y Alimentarias

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
CardonaDiana_2014_UtilidadColágenaPolivinilPirrolidona.pdfArtículo de investigación645.58 kBAdobe PDFVisualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons